IL-27, a heterodimeric cytokine composed of EB13 and p28 protein, induces proliferation of naive CD4+ T cells

被引:1176
作者
Pflanz, S [1 ]
Timans, JC [1 ]
Cheung, J [1 ]
Rosales, R [1 ]
Kanzler, H [1 ]
Gilbert, J [1 ]
Hibbert, L [1 ]
Churakova, T [1 ]
Travis, M [1 ]
Vaisberg, E [1 ]
Blumenschein, WM [1 ]
Mattson, JD [1 ]
Wagner, JL [1 ]
To, W [1 ]
Zurawski, S [1 ]
McClanahan, TK [1 ]
Gorman, DM [1 ]
Bazan, JF [1 ]
Malefyt, RD [1 ]
Rennick, D [1 ]
Kastelein, RA [1 ]
机构
[1] DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA
关键词
D O I
10.1016/S1074-7613(02)00324-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An efficient Th1-driven adaptive immune response requires activation of the T cell receptor and secretion of the T cell stimulatory cytokine IL-12 by activated antigen-presenting cells. IL-12 triggers Th1 polarization of naive CD4(+) T cells and secretion of IFN-gamma. We describe a new heterodimeric cytokine termed IL-27 that consists of EBI3, an IL-12p40-related protein, and p28, a newly discovered IL-12p35-related polypeptide. IL-27 is an early product of activated antigen-presenting cells and drives rapid clonal expansion of naive but not memory CD4+ T cells. It also strongly synergizes with IL-12 to trigger IFN-gamma production of naive CD4(+) T cells. IL-27 mediates its biologic effects through the orphan cytokine receptor WSX-1/TCCR.
引用
收藏
页码:779 / 790
页数:12
相关论文
共 31 条
[1]   Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): Delivery to acute myeloid leukemic blasts using adeno-associated virus [J].
Anderson, R ;
MacDonald, I ;
Corbet, T ;
Hacking, G ;
Lowdell, MW ;
Prentice, HG .
HUMAN GENE THERAPY, 1997, 8 (09) :1125-1135
[2]   HEMATOPOIETIC RECEPTORS AND HELICAL CYTOKINES [J].
BAZAN, JF .
IMMUNOLOGY TODAY, 1990, 11 (10) :350-354
[3]  
Bolin LM, 1997, J NEUROSCI, V17, P5493
[4]   Development of Th1-type immune responses requires the type I cytokine receptor TCCR [J].
Chen, Q ;
Ghilardi, N ;
Wang, H ;
Baker, T ;
Xie, MH ;
Gurney, A ;
Grewal, IS ;
de Sauvage, FJ .
NATURE, 2000, 407 (6806) :916-920
[5]  
David ZV, 1998, E EUR POLIT SOC, V12, P1
[6]   A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes [J].
Devergne, O ;
Hummel, M ;
Koeppen, H ;
LeBeau, MM ;
Nathanson, EC ;
Kieff, E ;
Birkenbach, M .
JOURNAL OF VIROLOGY, 1996, 70 (02) :1143-1153
[7]   Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin [J].
Devergne, O ;
Birkenbach, M ;
Kieff, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) :12041-12046
[8]   Expression of Epstein-Barrvirus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy -: Involvement of syncytiotrophoblasts and extravillous trophoblasts [J].
Devergne, O ;
Coulomb-L'Herminé, A ;
Capel, F ;
Moussa, M ;
Capron, F .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (05) :1763-1776
[9]   CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex [J].
Elson, GCA ;
Lelièvre, E ;
Guillet, C ;
Chevalier, S ;
Plun-Favreau, H ;
Froger, J ;
Suard, I ;
de Coignac, AB ;
Delneste, Y ;
Bonnefoy, JY ;
Gauchat, JF ;
Gascan, H .
NATURE NEUROSCIENCE, 2000, 3 (09) :867-872
[10]  
FISCHER M, 1997, NAT BIOTECHNOL, V69, P139